- Home
- Publications
- Publication Search
- Publication Details
Title
Personalized medicine: is it a pharmacogenetic mirage?
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume 74, Issue 4, Pages 698-721
Publisher
Wiley
Online
2012-05-16
DOI
10.1111/j.1365-2125.2012.04328.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Frequency of the C1236T, G2677T/A and C3435T MDR1 gene polymorphisms in the Serbian population
- (2014) Maja Milojkovic et al. Pharmacological Reports
- Assessment of Thiopurine S-Methyltransferase Activity in Patients Prescribed Thiopurines: A Systematic Review
- (2013) Ronald A. Booth et al. ANNALS OF INTERNAL MEDICINE
- A Randomized and Clinical Effectiveness Trial Comparing Two Pharmacogenetic Algorithms and Standard Care for Individualizing Warfarin Dosing (CoumaGen-II)
- (2012) Jeffrey L. Anderson et al. CIRCULATION
- Adoption of Pharmacogenomic Testing by US Physicians: Results of a Nationwide Survey
- (2012) E J Stanek et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes
- (2012) Raffaele De Caterina et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users
- (2012) T. I. VERHOEF et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Genotype-Based Dosing Algorithms for Warfarin Therapy
- (2012) Eric G. Johnson et al. Molecular Diagnosis & Therapy
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phenocopy and phenoconversion: do they complicate association studies?
- (2012) Rashmi R Shah et al. PHARMACOGENOMICS
- Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?
- (2011) Terry K. W. Ma et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Statin-Associated Rhabdomyolysis: Is There a Dose-Response Relationship?
- (2011) Anne Holbrook et al. CANADIAN JOURNAL OF CARDIOLOGY
- CYP2D6 Gene Variants and Their Association with Breast Cancer Susceptibility
- (2011) J. E. Abraham et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- CYP2C19 But Not PON1 Genetic Variants Influence Clopidogrel Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy in Post–Myocardial Infarction Patients
- (2011) Jean-Sébastien Hulot et al. Circulation-Cardiovascular Interventions
- Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary Interventions
- (2011) A L Beitelshees et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A Proposal for an Individualized Pharmacogenetics-Based Warfarin Initiation Dose Regimen for Patients Commencing Anticoagulation Therapy
- (2011) P J Avery et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
- (2011) J A Johnson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network
- (2011) M V Relling et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The Missing Association: Sequencing-Based Discovery of Novel SNPs in VKORC1 and CYP2C9 That Affect Warfarin Dose in African Americans
- (2011) M A Perera et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record
- (2011) J T Delaney et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Paraoxonase 1 (PON1) Gene Variants Are Not Associated With Clopidogrel Response
- (2011) J P Lewis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenetics: past, present and future
- (2011) Munir Pirmohamed DRUG DISCOVERY TODAY
- Similarities and Differences between US and Japan as to Pharmacogenomic Biomarker Information in Drug Labels
- (2011) Yasuto Otsubo et al. Drug Metabolism and Pharmacokinetics
- Pharmacogenomics of Tamoxifen: Roles of Drug Metabolizing Enzymes and Transporters
- (2011) Kazuma Kiyotani et al. Drug Metabolism and Pharmacokinetics
- A genome-wide association study identifies locus at 10q22 associated with clinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in Japanese
- (2011) Kazuma Kiyotani et al. HUMAN MOLECULAR GENETICS
- Dosing Clopidogrel Based on CYP2C19 Genotype and the Effect on Platelet Reactivity in Patients With Stable Cardiovascular Disease
- (2011) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events
- (2011) Michael V. Holmes et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Sex Differences in Drug Disposition
- (2011) Offie P. Soldin et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- CYP4F2 gene polymorphism as a contributor to warfarin maintenance dose in Japanese subjects
- (2011) K. Nakamura et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- P-Glycoprotein (ABCB1) Transports the Primary Active Tamoxifen Metabolites Endoxifen and 4-Hydroxytamoxifen and Restricts Their Brain Penetration
- (2011) D. Iusuf et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Physician liability: the next big thing for personalized medicine?
- (2011) Gary E Marchant et al. Personalized Medicine
- Genetic and nongenetic factors associated with warfarin doserequirements in Egyptian patients
- (2011) Mohamed Hossam A. Shahin et al. Pharmacogenetics and Genomics
- Letter to the Editor: Combined CYP2C9, VKORC1 and CYP4F2 frequencies among Amerindians, Mozambicans and Brazilians
- (2011) Daniela D Vargens et al. PHARMACOGENOMICS
- TheCYP2C19*2genotype predicts tamoxifen treatment outcome in advanced breast cancer patients
- (2011) Ron HN van Schaik et al. PHARMACOGENOMICS
- Survey of US public attitudes toward pharmacogenetic testing
- (2011) S B Haga et al. PHARMACOGENOMICS JOURNAL
- Genetics informatics trial (GIFT) of warfarin to prevent deep vein thrombosis (DVT): rationale and study design
- (2011) E J Do et al. PHARMACOGENOMICS JOURNAL
- Personalised medicine in Canada: a survey of adoption and practice in oncology, cardiology and family medicine
- (2011) K. Bonter et al. BMJ Open
- Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups
- (2010) N. A. Limdi et al. BLOOD
- Comprehensive CYP2D6 genotype and adherence affect outcome in breast cancer patients treated with tamoxifen monotherapy
- (2010) Alastair M. Thompson et al. BREAST CANCER RESEARCH AND TREATMENT
- CYP4F2 rs2108622: a minor significant genetic factor of warfarin dose in Han Chinese patients with mechanical heart valve replacement
- (2010) Han-Jing Cen et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
- (2010) Dirk Sibbing et al. CIRCULATION
- Prospective alpha allocation in the clarification of optimal anticoagulation through genetics (COAG) trial
- (2010) Jungnam Joo et al. Clinical Trials
- Endoxifen, the Active Metabolite of Tamoxifen, Is a Substrate of the Efflux Transporter P-Glycoprotein (Multidrug Resistance 1)
- (2010) W. A. Teft et al. DRUG METABOLISM AND DISPOSITION
- Genetic Variability and Haplotype Profile of MDR1 (ABCB1) in Roma and Hungarian Population Samples with a Review of the Literature
- (2010) Csilla Sipeky et al. Drug Metabolism and Pharmacokinetics
- Influence of CYP4F2 rs2108622 (V433M) on Warfarin Dose Requirement in Asian Patients
- (2010) Onkar Singh et al. Drug Metabolism and Pharmacokinetics
- Significant Effect of Polymorphisms inCYP2D6andABCC2on Clinical Outcomes of Adjuvant Tamoxifen Therapy for Breast Cancer Patients
- (2010) Kazuma Kiyotani et al. JOURNAL OF CLINICAL ONCOLOGY
- Drug-drug interactions that reduce the formation of pharmacologically active metabolites: a poorly understood problem in clinical practice
- (2010) B. Mannheimer et al. JOURNAL OF INTERNAL MEDICINE
- ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
- (2010) David R. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
- (2010) Jessica L Mega et al. LANCET
- Paraoxonase-1 is a major determinant of clopidogrel efficacy
- (2010) Heleen J Bouman et al. NATURE MEDICINE
- Lessons for pharmacogenomics studies: association study between CYP2D6 genotype and tamoxifen response
- (2010) Kazuma Kiyotani et al. Pharmacogenetics and Genomics
- CYP2C19*2polymorphism is associated with increased survival in breast cancer patients using tamoxifen
- (2010) Rikje Ruiter et al. PHARMACOGENOMICS
- Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice
- (2010) Alessio Squassina et al. PHARMACOGENOMICS
- An overview of the recent progress in irinotecan pharmacogenetics
- (2010) Yutaka Fujiwara et al. PHARMACOGENOMICS
- VKORC1,CYP2C9andCYP4F2genetic-based algorithm for warfarin dosing: an Italian retrospective study
- (2010) Carlo-Federico Zambon et al. PHARMACOGENOMICS
- Practical recommendations for pharmacogenomics-based prescription: 2010 ESF–UB Conference on Pharmacogenetics and Pharmacogenomics
- (2010) Laurent Becquemont et al. PHARMACOGENOMICS
- Gender differences in drug toxicity
- (2010) Tamara J. Nicolson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Relation of Cytochrome P450 2C19 Loss-of-Function Polymorphism to Occurrence of Drug-Eluting Coronary Stent Thrombosis
- (2009) Betti Giusti et al. AMERICAN JOURNAL OF CARDIOLOGY
- A population-based study of the drug interaction between proton pump inhibitors and clopidogrel
- (2009) D. N. Juurlink et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Cost-Effectiveness of Genotype-Guided Warfarin Dosing for Patients With Atrial Fibrillation
- (2009) Amanda R. Patrick et al.
- Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: 2009 Update by the HIV Medicine Association of the Infectious Diseases Society of America
- (2009) Judith A. Aberg et al. CLINICAL INFECTIOUS DISEASES
- Cytochrome P450 2C19 loss-of-function polymorphism and stent thrombosis following percutaneous coronary intervention
- (2009) D. Sibbing et al. EUROPEAN HEART JOURNAL
- Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: old drug, new hope
- (2009) Thanh Trung Phan et al. EUROPEAN JOURNAL OF HEART FAILURE
- Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain
- (2009) David Gurwitz et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin
- (2009) David A Flockhart et al. GENETICS IN MEDICINE
- Can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? An evidence-based review
- (2009) Glenn E Palomaki et al. GENETICS IN MEDICINE
- Personalized medicine: Factors influencing reimbursement
- (2009) Lisa M. Meckley et al. HEALTH POLICY
- UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
- (2009) Masahide Onoue et al. International Journal of Clinical Oncology
- Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen
- (2009) Werner Schroth JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Detection of C1236T, G2677T/A, and C3435T polymorphism ofMDR1by amplification refractory mutation system PCR
- (2009) Bing Chen et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Comprehensive Pharmacogenetic Analysis of Irinotecan Neutropenia and Pharmacokinetics
- (2009) Federico Innocenti et al. JOURNAL OF CLINICAL ONCOLOGY
- The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome
- (2009) C. FRÉRE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
- (2009) Ann K Daly et al. NATURE GENETICS
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population
- (2009) Paola Borgiani et al. PHARMACOGENOMICS
- Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design
- (2009) Rianne MF van Schie et al. PHARMACOGENOMICS
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- CYP4F2 genetic variant alters required warfarin dose
- (2008) M. D. Caldwell et al. BLOOD
- Life-threatening toxicities in a patient with UGT1A1*6/*28 and SLCO1B1*15/*15 genotypes after irinotecan-based chemotherapy
- (2008) Hiroshi Takane et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy
- (2008) Kazuma Kiyotani et al. CANCER SCIENCE
- High Sensitivity of Human Leukocyte Antigen–B*5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients
- (2008) Michael Saag et al. CLINICAL INFECTIOUS DISEASES
- Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin
- (2008) BF Gage et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pharmacogenomics of 4-Hydroxycoumarin Anticoagulants
- (2008) Nicholas Au et al. DRUG METABOLISM REVIEWS
- From Human Genetics and Genomics to Pharmacogenetics and Pharmacogenomics: Past Lessons, Future Directions
- (2008) Daniel W. Nebert et al. DRUG METABOLISM REVIEWS
- Women encounter ADRs more often than do men
- (2008) Y. Zopf et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Genetic Determinants of Response to Warfarin during Initial Anticoagulation
- (2008) Ute I. Schwarz et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Payer perspectives on pharmacogenomics testing and drug development
- (2008) Robert S Epstein et al. PHARMACOGENOMICS
- Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility
- (2008) A R Hughes et al. PHARMACOGENOMICS JOURNAL
- Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use
- (2008) Felix W Frueh et al. PHARMACOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now